| Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes W Liu, M Onda, B Lee, RJ Kreitman, R Hassan, L Xiang, I Pastan Proceedings of the National Academy of Sciences 109 (29), 11782-11787, 2012 | 182 | 2012 |
| A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity W Liu, M Onda, C Kim, L Xiang, JE Weldon, B Lee, I Pastan Protein Engineering, Design & Selection 25 (1), 1-6, 2012 | 35 | 2012 |
| The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor W Liu, M Kawahara, H Ueda, T Nagamune Journal of biochemistry 145 (5), 575-584, 2009 | 33 | 2009 |
| Identification of an inducible glucosyltransferase from Phytolacca americana L. cells that are capable of glucosylating capsaicin A Noguchi, S Kunikane, H Homma, W Liu, T Sekiya, M Hosoya, S Kwon, ... Plant biotechnology 26 (3), 285-292, 2009 | 32 | 2009 |
| Construction of a fluorescein‐responsive chimeric receptor with strict ligand dependency W Liu, M Kawahara, H Ueda, T Nagamune Biotechnology and bioengineering 101 (5), 975-984, 2008 | 31 | 2008 |
| Megakaryocytic potentiating factor and mature mesothelin stimulate the growth of a lung cancer cell line in the peritoneal cavity of mice J Zhang, TK Bera, W Liu, X Du, C Alewine, R Hassan, I Pastan PLoS One 9 (8), e104388, 2014 | 13 | 2014 |
| Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2 W Liu, A Menoret, AT Vella Cellular & Molecular Immunology 14 (3), 254-264, 2017 | 12 | 2017 |
| TNF and CD28 signaling play unique but complementary roles in the systemic recruitment of innate immune cells after Staphylococcus aureus enterotoxin A inhalation J Svedova, N Tsurutani, W Liu, KM Khanna, AT Vella The Journal of Immunology 196 (11), 4510-4521, 2016 | 8 | 2016 |
| Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes IH Pastan, R Mazor, M Onda, A Vassall, R Beers, J Eberle, W Liu US Patent 9,346,859, 2016 | 8 | 2016 |
| Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production P Shinde, W Liu, A Ménoret, AD Luster, AT Vella Journal of leukocyte biology 102 (1), 57-69, 2017 | 5 | 2017 |
| Pseudomonas exotoxin A with less immunogenic B cell epitopes IH Pastan, M Onda, W Liu US Patent 9,206,240, 2015 | 4 | 2015 |
| Pseudomonas exotoxin A with less immunogenic B cell epitopes IH Pastan, M Onda, W Liu US Patent 9,657,066, 2017 | 2 | 2017 |
| Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope XF Liu, M Onda, J Schlomer, L Bassel, S Kozlov, CH Tai, Q Zhou, W Liu, ... Proceedings of the National Academy of Sciences 121 (4), e2317283121, 2024 | 1 | 2024 |
| An improved lentiviral system for efficient expression and purification of β‐defensins in mammalian cells S Ahmed, J Tao, M Wang, Y Zhai, W Liu, M Jayachandran, C Chu, S Qu, ... Biotechnology Journal 16 (9), 2100023, 2021 | 1 | 2021 |
| Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes IH Pastan, R Mazor, M Onda, A Vassall, R Beers, J Eberle, W Liu US Patent 9,765,123, 2017 | 1 | 2017 |
| Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes IH Pastan, R Mazor, M Onda, A Vassall, R Beers, J Eberle, W Liu US Patent 10,428,119, 2019 | | 2019 |
| Pseudomonas exotoxin A with less immunogenic B cell epitopes IH Pastan, M Onda, W Liu US Patent 10,111,927, 2018 | | 2018 |
